Shares of Regencell Bioscience Holdings Limited (RGC) have been firing on all cylinders since March 13, 2025, following the release of an SEC filing that day.
The filing revealed that on March 10, 2025, Regencell (BVI) Limited, acting as the buyer, entered into a Sale and Purchase Agreement with a third-party shareholder of the company, the seller. Under the terms of the agreement, Regencell (BVI) Limited agreed to acquire 652,982 ordinary shares from the seller for a total of $6.2 million or $9.50 per share, subject to the agreed-upon terms and conditions. The buyback was funded by Yat-Gai Au, the CEO of Regencell.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com